This segment focuses on the research, development, and commercialization of electrophysiology catheters and delivery systems used in the diagnosis and treatment of cardiac arrhythmias. R&D activities include the development of advanced catheter designs, mapping technologies, and ablation techniques, such as pulsed field ablation (PFA). Technologies employed include radiofrequency ablation, 3D mapping systems, and advanced catheter materials. The therapeutic area is cardiology, specifically the treatment of atrial fibrillation, ventricular tachycardia, and other complex arrhythmias. Patient impact is significant, as these devices enable minimally invasive procedures to restore normal heart rhythm, improving quality of life and reducing the risk of stroke and heart failure. APT Medical's market positioning is strong in China, with a growing presence globally. Future opportunities include expanding the product portfolio with innovative catheter designs and exploring new ablation modalities. Regulatory and clinical aspects involve obtaining NMPA and other international approvals, and conducting clinical trials to demonstrate safety and efficacy. Partnerships and collaborations are essential for technology advancements and market expansion.

This segment encompasses the development, manufacturing, and sales of vascular intervention products, including diagnostic and treatment products, and intervention accessories. Research and development efforts focus on creating innovative devices for treating cardiovascular and cerebrovascular diseases, such as coronary artery disease, peripheral artery disease, and stroke. Technologies include stent grafts, balloon catheters, guide wires, and embolic protection devices. The therapeutic areas covered are cardiology and neurology, with a focus on improving outcomes for patients with vascular conditions. Patient impact is substantial, as these products enable minimally invasive procedures to restore blood flow, prevent stroke, and improve overall vascular health. APT Medical aims to strengthen its market position in China and expand globally. Future opportunities include developing advanced stent technologies, drug-eluting devices, and embolic protection systems. Regulatory and clinical aspects involve obtaining necessary approvals and conducting clinical trials to demonstrate product safety and efficacy. Partnerships and collaborations with hospitals and research institutions are crucial for product development and market access.